113 related articles for article (PubMed ID: 38615287)
1. Immune-related LncRNAs scores predicts chemotherapeutic responses and prognosis in cervical cancer patients.
Tian W; Tan S; Wang J; Shen P; Qin Q; Zi D
Discov Oncol; 2024 Apr; 15(1):119. PubMed ID: 38615287
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma.
Jiang Y; Gou X; Wei Z; Tan J; Yu H; Zhou X; Li X
Cancer Cell Int; 2020; 20():166. PubMed ID: 32435157
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma.
Ping S; Wang S; He J; Chen J
Pharmgenomics Pers Med; 2021; 14():667-681. PubMed ID: 34113151
[TBL] [Abstract][Full Text] [Related]
4. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
Front Genet; 2022; 13():938250. PubMed ID: 36561319
[No Abstract] [Full Text] [Related]
5. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
Wang S; Bai H; Fei S; Miao B
Biochem Genet; 2023 Oct; ():. PubMed ID: 37898914
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
Front Oncol; 2023; 13():972558. PubMed ID: 37064115
[TBL] [Abstract][Full Text] [Related]
7. Exploration of the Immune-Related Long Noncoding RNA Prognostic Signature and Inflammatory Microenvironment for Cervical Cancer.
Yao H; Jiang X; Fu H; Yang Y; Jin Q; Zhang W; Cao W; Gao W; Wang S; Zhu Y; Ying J; Tian L; Chen G; Tong Z; Qi J; Zhou S
Front Pharmacol; 2022; 13():870221. PubMed ID: 35662687
[No Abstract] [Full Text] [Related]
8. Autophagy-related long non-coding RNA signature for potential prognostic biomarkers of patients with cervical cancer: a study based on public databases.
Feng Q; Wang J; Cui N; Liu X; Wang H
Ann Transl Med; 2021 Nov; 9(22):1668. PubMed ID: 34988177
[TBL] [Abstract][Full Text] [Related]
9. Identification and Experimental Validation of Immune-Associate lncRNAs for Predicting Prognosis in Cervical Cancer.
Ye J; Chen X; Lu W
Onco Targets Ther; 2021; 14():4721-4734. PubMed ID: 34526775
[TBL] [Abstract][Full Text] [Related]
10. Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma.
Shi Y; Zhang Y; Zuo N; Wang L; Sun X; Liang L; Ju M; Di X
Medicine (Baltimore); 2023 Jun; 102(23):e33994. PubMed ID: 37335630
[TBL] [Abstract][Full Text] [Related]
11. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive study of a novel immune-related lncRNA for prognosis and drug treatment of cervical squamous cell carcinoma.
Liu J; Liu Y; Gao F; Zhang J; Pan J; Liu Y; Zhu H
Am J Transl Res; 2021; 13(10):11771-11785. PubMed ID: 34786106
[TBL] [Abstract][Full Text] [Related]
13. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract][Full Text] [Related]
14. Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients.
Qiu Y; Wang HT; Zheng XF; Huang X; Meng JZ; Huang JP; Wen ZP; Yao J
World J Clin Cases; 2022 Apr; 10(11):3334-3351. PubMed ID: 35611195
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database.
Wu W; Sui J; Liu T; Yang S; Xu S; Zhang M; Huang S; Yin L; Pu Y; Liang G
PeerJ; 2019; 7():e6761. PubMed ID: 31065456
[TBL] [Abstract][Full Text] [Related]
16. An immune-associated ten-long noncoding RNA signature for predicting overall survival in cervical cancer.
Dai S; Yao D
Transl Cancer Res; 2021 Dec; 10(12):5295-5306. PubMed ID: 35116378
[TBL] [Abstract][Full Text] [Related]
17. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
18. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
[TBL] [Abstract][Full Text] [Related]
19. The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma.
Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; de Castria TB; Zeng B; Zong Z; Zhou T
Ann Transl Med; 2022 Jul; 10(14):766. PubMed ID: 35965795
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients.
Jiang ZR; Yang LH; Jin LZ; Yi LM; Bing PP; Zhou J; Yang JS
Front Oncol; 2022; 12():988680. PubMed ID: 36203428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
